[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100623361":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":32,"locations":41,"responsibleParty":64,"collaborators":18,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":18,"eligibilityCriteria":73,"healthyVolunteers":69,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":18,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":87,"overallStatus":44,"whyStopped":18,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Tata Memorial Centre","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Arm","EXPERIMENTAL","Immunomax® Powder- Participant in this group will receive Immunomac Powder 7 consecutive days preceding surgery in a dose of 6-9 scoops (120-180g per day), based on their bodyweight.",[13],"Dietary Supplement: Immunonutrition",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard Arm","NO_INTERVENTION","Participant in this group will be advised to continue with their usual oral intake. Patients in this group assessed as having malnutrition will be provided with a standard nutritional supplement (Fortisip®, Nutricia) twice daily (providing 600 kcal energy, 24 g protein), in addition to their usual intake, for the period preceding and including 7 days prior to surgery",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DIETARY_SUPPLEMENT","Immunonutrition","In addition to their usual intake, patients in the intervention arm will be prescribed for each of the 7 consecutive days preceding surgery 6-9 scoops PENTASURE Immunomax® powder (120-180g per day)",[9],[26],"PENTASURE IMMUNOMAX POWDER",[28],{"name":29,"affiliation":30,"role":31},"Dr. Shraddha Patkar, MD MCh","Professor and surgeon","PRINCIPAL_INVESTIGATOR",[33,37],{"name":29,"role":34,"phone":35,"phoneExt":18,"email":36},"CONTACT","9820074818","drshraddhapatkar@gmail.com",{"name":38,"role":34,"phone":39,"phoneExt":18,"email":40},"Dr Mahesh Goel, MBBS, MD","9820504492","drmaheshgoel@gmail.com",[42],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Dr. Shraddha Patkar","RECRUITING","Mumbai","Maharashtra","400012","India","IN",{"type":51,"coordinates":52},"Point",[53,54],72.88261,19.07283,{"lat":54,"lon":53},[57,58,59,62],{"name":29,"role":34,"phone":35,"phoneExt":18,"email":36},{"name":29,"role":31,"phone":18,"phoneExt":18,"email":18},{"name":60,"role":61,"phone":18,"phoneExt":18,"email":18},"Dr. Mahesh Goel, MBBS, MD","SUB_INVESTIGATOR",{"name":63,"role":61,"phone":18,"phoneExt":18,"email":18},"Dr. Sridhar Sundaram, MBBS, MD",{"type":31,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Dr Shraddha Patkar","Professor and Surgeon","100623361","phase-ii-trial-of-immunonutrition-in-hepatectomy-100623361",false,"NCT07395635","Phase II Trial of Immunonutrition in Hepatectomy","Impact of Immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors: A Randomized Controlled Phase II Trial","Inclusion Criteria:\n\n1. Patients with liver tumors planned for major hepatectomies (defined as resection of \\>\u002F= 3 liver segments)\n2. Age above 18 years\n3. ASA class I-III\n\nExclusion Criteria:\n\n1. Preoperative severe renal failure (estimated glomerular filtration rate \\\u003C 30 ml\u002Fmin)\n2. History of hypersensitivity to arginine, omega-3 fatty acids, or nucleotide 3. Inability to take oral nutrition\n\n4\\. Pregnancy 5. Mental condition rendering the subject unable to understand the nature, endpoints and consequences of the trial","ALL","18 Years","90 Years",{"count":78,"type":79},100,"ESTIMATED","INTERVENTIONAL",[82],"NA","A randomised open labelled study to evalaute the impact of immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors",[85,86],"Hepatocellular Carcinoma","ASA I-III Patients",[22,88],"Hepatectomy","2026-02-06",{"date":91,"type":92},"2026-02-09","ACTUAL",{"date":94,"type":92},"2025-10-03",{"date":96,"type":79},"2028-01-31",{"name":5,"class":6},1]